$1.27
At close: Apr 14, 4:00 PM EDT
$1.27
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Macrogenics Insider Trading Activity | NASDAQ:MGNX | Benzinga
Track the latest Macrogenics insider trading activity. Stay informed on recent buys, sells, and market impact for Macrogenics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Macrogenics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Macrogenics Inc
Shares Outstanding
63.090M
Insider Shares Owned
1.490M
Insider Percentage Owned
2.36%
Institutional Shares Held
29.185M
Institutional Percentage Held
46.3%
| Feb 19, 2025 | Beth Smith | VP, CONTROLLER & TREASURER | 672.00 | $2.56 | -$1.08K | SELL-OPTIONS | 7.58% | 9.53K | Feb 15 | View |
| Apr 08, 2024 | Stuart Jeffrey Peters | SENIOR VP AND GENERAL COUNSEL | -8.89K | $10.18 | -$594.30K | SELL | -100.00% | 0.00 | Apr 04 | View |
| Mar 08, 2024 | Stuart Jeffrey Peters | SENIOR VP AND GENERAL COUNSEL | 0.00 | $16.20 | -$208.06K | SELL-OPTIONS | 0.00% | 8.89K | Mar 06 | View |
| Mar 06, 2024 | Blasius Eric Risser | CHIEF OPERATING OFFICER | -26.16K | $14.96 | -$661.25K | SELL | -40.21% | 38.90K | Mar 04 | View |
| Mar 06, 2024 | Thomas Spitznagel | SR VP, TECHNICAL OPS | 0.00 | $15.75 | -$85.00K | SELL-OPTIONS | 0.00% | 8.32K | Mar 04 | View |
| Mar 06, 2024 | James Karrels | SVP, CFO AND SECRETARY | -30.00K | $20.50 | -$615.00K | SELL | -14.89% | 171.45K | Mar 04 | View |
| Feb 28, 2024 | Stuart Jeffrey Peters | SENIOR VP AND GENERAL COUNSEL | -16.12K | $17.22 | -$277.66K | SELL | -64.45% | 8.89K | Feb 26 | View |
| Feb 07, 2024 | Ezio Bonvini | SR VP, RESEARCH & CSO | -3.33K | $18.00 | -$60.01K | SELL | -4.47% | 71.33K | Feb 07 | View |
| Feb 07, 2024 | Stuart Jeffrey Peters | SENIOR VP AND GENERAL COUNSEL | 0.00 | $13.81 | -$410.79K | SELL-OPTIONS | 0.00% | 0.00 | Feb 05 | View |
| Feb 02, 2024 | Ezio Bonvini | SR VP, RESEARCH & CSO | -13.32K | $15.00 | -$199.74K | SELL | -15.13% | 74.67K | Feb 01 | View |
| Jan 22, 2024 | Ezio Bonvini | SR VP, RESEARCH & CSO | -13.32K | $12.00 | -$159.79K | SELL | -13.15% | 87.98K | Jan 19 | View |
| Dec 21, 2023 | Ezio Bonvini | SR VP, RESEARCH & CSO | -18.88K | $10.08 | -$190.31K | SELL | -15.71% | 101.30K | Dec 20 | View |
| Oct 04, 2023 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 150.00K | $4.46 | $669.59K | BUY | 1.53% | 9.93M | Oct 02 | View |
| Sep 11, 2023 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 200.00K | $5.26 | $1.05M | BUY | 2.09% | 9.78M | Sep 07 | View |
| Sep 01, 2023 | EDWARD HURWITZ | DIRECTOR | 15.00K | $4.91 | $73.65K | BUY | 82.99% | 33.07K | Aug 30 | View |
| Mar 14, 2023 | Stuart Jeffrey Peters | SENIOR VP AND GENERAL COUNSEL | -5.37K | $6.03 | -$32.39K | SELL | -100.00% | 0.00 | Mar 10 | View |
| Feb 16, 2023 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 500.00K | $5.07 | $2.53M | BUY | 5.51% | 9.58M | Feb 14 | View |
| Jan 23, 2023 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 150.00K | $5.30 | $794.92K | BUY | 1.68% | 9.08M | Jan 19 | View |
| Dec 28, 2022 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 400.00K | $5.75 | $2.30M | BUY | 4.69% | 8.93M | Dec 23 - Dec 27 | View |
| Nov 25, 2022 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 300.00K | $5.96 | $1.79M | BUY | 3.65% | 8.53M | Nov 22 | View |
| Oct 25, 2022 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 500.00K | $4.50 | $2.25M | BUY | 6.47% | 8.23M | Oct 21 - Oct 24 | View |
| Oct 21, 2022 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 454.40K | $3.89 | $1.77M | BUY | 6.25% | 7.73M | Oct 19 - Oct 20 | View |
| Jun 17, 2022 | James Karrels | SVP, CFO AND SECRETARY | 40.00K | $2.47 | $98.80K | BUY | 26.35% | 191.78K | Jun 15 | View |
| Nov 23, 2021 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 200.00K | $18.50 | $3.70M | BUY | 2.83% | 7.28M | Nov 19 | View |
| Sep 30, 2021 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 200.00K | $20.56 | $4.11M | BUY | 2.91% | 7.08M | Sep 28 - Sep 29 | View |
| Sep 20, 2021 | TARGET BIOTECH VBB BIOTECH AG | 10% OWNER | 600.00K | $20.61 | $12.36M | BUY | 9.56% | 6.88M | Sep 16 - Sep 17 | View |
| Jul 20, 2021 | Thomas Spitznagel | SR VP, BPD & MANUFACTURING | 0.00 | $16.26 | -$87.50K | SELL-OPTIONS | 0.00% | 0.00 | Jul 16 | View |
| Jun 23, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 75.00K | $21.74 | $1.63M | BUY | 1.21% | 6.28M | Jun 21 | View |
| Jun 17, 2021 | TARGET BIOTECH VAG BIOTECH BB | 10% OWNER | 175.00K | $20.82 | $3.64M | BUY | 2.90% | 6.20M | Jun 15 - Jun 16 | View |
| Apr 19, 2021 | Thomas Spitznagel | SR VP, BPD & MANUFACTURING | 0.00 | $19.21 | -$117.00K | SELL-OPTIONS | 0.00% | 0.00 | Apr 15 | View |
| Mar 24, 2021 | James Karrels | SVP, CFO AND SECRETARY | -15.00K | $33.00 | -$495.00K | SELL | -9.47% | 143.46K | Mar 22 | View |
| Mar 24, 2021 | Ezio Bonvini | SR VP, RESEARCH & CSO | -3.92K | $32.00 | -$125.34K | SELL | -4.67% | 79.89K | Mar 22 | View |
| Mar 09, 2021 | Stuart Jeffrey Peters | GENERAL COUNSEL | 0.00 | $19.00 | -$326.24K | SELL-OPTIONS | 0.00% | 0.00 | Mar 08 | View |
| Dec 30, 2020 | Blasius Eric Risser | — | 0.00 | $12.81 | -$11.29K | OPTION EXERCISE | 0.00% | 44.47K | Dec 29 | View |
| Dec 01, 2020 | Blasius Eric Risser | — | 0.00 | $12.43 | -$10.92K | OPTION EXERCISE | 0.00% | 44.47K | Nov 30 | View |
| Oct 29, 2020 | Blasius Eric Risser | — | 0.00 | $11.10 | -$28.77K | OPTION EXERCISE | 0.00% | 44.47K | Oct 28 | View |
| Sep 29, 2020 | Blasius Eric Risser | — | 0.00 | $13.42 | -$11.91K | OPTION EXERCISE | 0.00% | 44.47K | Sep 28 | View |
| Sep 21, 2020 | Ezio Bonvini | — | -62.85K | $30.50 | -$1.92M | SELL | -42.86% | 83.81K | Sep 17 - Sep 18 | View |
| Sep 10, 2020 | Kenneth Galbraith | — | 0.00 | $22.25 | -$202.05K | OPTION EXERCISE | 0.00% | 0.00 | Sep 09 | View |
| Aug 27, 2020 | Blasius Eric Risser | — | 0.00 | $14.30 | -$12.79K | OPTION EXERCISE | 0.00% | 44.47K | Aug 26 | View |
| Aug 21, 2020 | Thomas Spitznagel | — | 0.00 | $17.19 | -$145.20K | OPTION EXERCISE | 0.00% | 0.00 | Aug 20 | View |
| Jul 28, 2020 | Blasius Eric Risser | — | 0.00 | $13.46 | -$107.82K | OPTION EXERCISE | 0.00% | 44.47K | Jul 27 | View |
| Jul 06, 2020 | Stuart Jeffrey Peters | — | -202.00 | $30.00 | -$6.06K | SELL | -100.00% | 0.00 | Jul 02 | View |
| Jul 06, 2020 | Blasius Eric Risser | — | 0.00 | $15.76 | -$88.32K | OPTION EXERCISE | 0.00% | 44.47K | Jul 02 | View |
| Jun 25, 2020 | Blasius Eric Risser | — | 0.00 | $14.71 | -$13.78K | OPTION EXERCISE | 0.00% | 44.47K | Jun 24 | View |
| May 27, 2020 | Blasius Eric Risser | — | 0.00 | $13.77 | -$12.82K | OPTION EXERCISE | 0.00% | 44.47K | May 26 | View |
| May 21, 2020 | Thomas Spitznagel | — | 0.00 | $16.41 | -$133.43K | OPTION EXERCISE | 0.00% | 0.00 | May 20 | View |
| May 07, 2020 | Blasius Eric Risser | — | 0.00 | $11.21 | -$156.46K | OPTION EXERCISE | 0.00% | 44.47K | May 06 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.